Compounds as semaphorin inhibitors
1 3 2 4 Compounds represented by the general formula (1) wherein Rand Rare each independently hydrogen or a carboxyl group and Rand Rare each independently hydrogen or a hydroxyl group, or pharmaceutically acceptable salts thereof, which exhibit semaphorin-inhibitory activity and are useful as preve...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Kumagai, Kazuo Hosotani, Nobuo |
description | 1 3 2 4 Compounds represented by the general formula (1) wherein Rand Rare each independently hydrogen or a carboxyl group and Rand Rare each independently hydrogen or a hydroxyl group, or pharmaceutically acceptable salts thereof, which exhibit semaphorin-inhibitory activity and are useful as preventives or remedies for neuropathic and neurodegenerative diseases are provided. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07642362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07642362</sourcerecordid><originalsourceid>FETCH-uspatents_grants_076423623</originalsourceid><addsrcrecordid>eNrjZFByzs8tyC_NSylWSCxWKE7NTSzIyC_KzFPIzMvITMosyS8q5mFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJIMrA3MzEyNjMyJgIJQC3qydQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Compounds as semaphorin inhibitors</title><source>USPTO Issued Patents</source><creator>Kumagai, Kazuo ; Hosotani, Nobuo</creator><creatorcontrib>Kumagai, Kazuo ; Hosotani, Nobuo ; Dainippon Sumitomo Pharma Co., Ltd</creatorcontrib><description>1 3 2 4 Compounds represented by the general formula (1) wherein Rand Rare each independently hydrogen or a carboxyl group and Rand Rare each independently hydrogen or a hydroxyl group, or pharmaceutically acceptable salts thereof, which exhibit semaphorin-inhibitory activity and are useful as preventives or remedies for neuropathic and neurodegenerative diseases are provided.</description><language>eng</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7642362$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7642362$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Kumagai, Kazuo</creatorcontrib><creatorcontrib>Hosotani, Nobuo</creatorcontrib><creatorcontrib>Dainippon Sumitomo Pharma Co., Ltd</creatorcontrib><title>Compounds as semaphorin inhibitors</title><description>1 3 2 4 Compounds represented by the general formula (1) wherein Rand Rare each independently hydrogen or a carboxyl group and Rand Rare each independently hydrogen or a hydroxyl group, or pharmaceutically acceptable salts thereof, which exhibit semaphorin-inhibitory activity and are useful as preventives or remedies for neuropathic and neurodegenerative diseases are provided.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZFByzs8tyC_NSylWSCxWKE7NTSzIyC_KzFPIzMvITMosyS8q5mFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJIMrA3MzEyNjMyJgIJQC3qydQ</recordid><startdate>20100105</startdate><enddate>20100105</enddate><creator>Kumagai, Kazuo</creator><creator>Hosotani, Nobuo</creator><scope>EFH</scope></search><sort><creationdate>20100105</creationdate><title>Compounds as semaphorin inhibitors</title><author>Kumagai, Kazuo ; Hosotani, Nobuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_076423623</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Kumagai, Kazuo</creatorcontrib><creatorcontrib>Hosotani, Nobuo</creatorcontrib><creatorcontrib>Dainippon Sumitomo Pharma Co., Ltd</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Kumagai, Kazuo</au><au>Hosotani, Nobuo</au><aucorp>Dainippon Sumitomo Pharma Co., Ltd</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Compounds as semaphorin inhibitors</title><date>2010-01-05</date><risdate>2010</risdate><abstract>1 3 2 4 Compounds represented by the general formula (1) wherein Rand Rare each independently hydrogen or a carboxyl group and Rand Rare each independently hydrogen or a hydroxyl group, or pharmaceutically acceptable salts thereof, which exhibit semaphorin-inhibitory activity and are useful as preventives or remedies for neuropathic and neurodegenerative diseases are provided.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_07642362 |
source | USPTO Issued Patents |
title | Compounds as semaphorin inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T06%3A28%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Kumagai,%20Kazuo&rft.aucorp=Dainippon%20Sumitomo%20Pharma%20Co.,%20Ltd&rft.date=2010-01-05&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07642362%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |